Jamie Or Brett, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor alpha | 2 | 2023 | 577 | 0.760 |
Why?
|
Cyclin D1 | 1 | 2020 | 463 | 0.630 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 362 | 0.560 |
Why?
|
Muscle, Skeletal | 5 | 2024 | 4931 | 0.520 |
Why?
|
Breast Neoplasms | 4 | 2023 | 20822 | 0.510 |
Why?
|
Adult Stem Cells | 3 | 2024 | 216 | 0.450 |
Why?
|
Disease | 1 | 2014 | 680 | 0.330 |
Why?
|
Aromatase Inhibitors | 2 | 2023 | 491 | 0.320 |
Why?
|
Stem Cells | 2 | 2023 | 3567 | 0.310 |
Why?
|
Multigene Family | 1 | 2011 | 1102 | 0.300 |
Why?
|
Neural Stem Cells | 2 | 2013 | 851 | 0.300 |
Why?
|
Longevity | 1 | 2014 | 1070 | 0.280 |
Why?
|
Neurogenesis | 2 | 2011 | 838 | 0.250 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2023 | 1524 | 0.230 |
Why?
|
S-Adenosylmethionine | 1 | 2024 | 212 | 0.210 |
Why?
|
Heterochromatin | 1 | 2024 | 296 | 0.200 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2021 | 129 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2023 | 538 | 0.180 |
Why?
|
Hydroxamic Acids | 1 | 2022 | 494 | 0.170 |
Why?
|
Cell Differentiation | 5 | 2024 | 11483 | 0.160 |
Why?
|
Tamoxifen | 1 | 2023 | 981 | 0.160 |
Why?
|
Aging | 3 | 2024 | 8664 | 0.160 |
Why?
|
Satellite Cells, Skeletal Muscle | 2 | 2022 | 124 | 0.160 |
Why?
|
Cell Transplantation | 1 | 2020 | 477 | 0.160 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2021 | 671 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5172 | 0.150 |
Why?
|
Myoblasts | 1 | 2017 | 238 | 0.140 |
Why?
|
Myoblasts, Skeletal | 1 | 2016 | 76 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5535 | 0.130 |
Why?
|
Tissue Preservation | 1 | 2016 | 182 | 0.130 |
Why?
|
Cell Proliferation | 1 | 2011 | 10481 | 0.130 |
Why?
|
MicroRNAs | 1 | 2011 | 3752 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3479 | 0.120 |
Why?
|
Cell Separation | 1 | 2020 | 1751 | 0.120 |
Why?
|
Signal Transduction | 2 | 2014 | 23403 | 0.120 |
Why?
|
Indoles | 1 | 2022 | 1839 | 0.110 |
Why?
|
Receptors, Estrogen | 1 | 2021 | 2187 | 0.110 |
Why?
|
Receptor, erbB-2 | 1 | 2023 | 2416 | 0.110 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 1613 | 0.110 |
Why?
|
Stem Cell Niche | 1 | 2016 | 346 | 0.110 |
Why?
|
Disease-Free Survival | 1 | 2023 | 6895 | 0.110 |
Why?
|
Sirtuin 1 | 1 | 2013 | 246 | 0.100 |
Why?
|
Mice | 11 | 2024 | 81183 | 0.100 |
Why?
|
Mutation | 3 | 2023 | 29786 | 0.100 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 379 | 0.100 |
Why?
|
Cell Cycle | 2 | 2022 | 2967 | 0.090 |
Why?
|
Muscle Proteins | 1 | 2016 | 1159 | 0.090 |
Why?
|
Oligodendroglia | 1 | 2013 | 517 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2020 | 5974 | 0.090 |
Why?
|
Animals | 12 | 2024 | 168757 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2022 | 9438 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1119 | 0.080 |
Why?
|
Disease Progression | 1 | 2023 | 13284 | 0.070 |
Why?
|
Female | 6 | 2024 | 380194 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2109 | 0.060 |
Why?
|
Cells, Cultured | 4 | 2016 | 19229 | 0.060 |
Why?
|
Polyamines | 1 | 2024 | 120 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 2007 | 0.050 |
Why?
|
Humans | 6 | 2024 | 744343 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.050 |
Why?
|
Stem Cell Transplantation | 2 | 2022 | 1620 | 0.050 |
Why?
|
Muscles | 1 | 2024 | 1614 | 0.040 |
Why?
|
Oxygen | 1 | 2009 | 4189 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9583 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2017 | 21827 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16365 | 0.040 |
Why?
|
Cell Division | 1 | 2024 | 4568 | 0.030 |
Why?
|
Insulin | 1 | 2011 | 6580 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2022 | 9734 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2023 | 77449 | 0.030 |
Why?
|
Cell Lineage | 2 | 2013 | 2504 | 0.030 |
Why?
|
Neurons | 1 | 2009 | 9338 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 697 | 0.020 |
Why?
|
Myelin Sheath | 1 | 2013 | 652 | 0.020 |
Why?
|
Brain | 2 | 2013 | 26385 | 0.020 |
Why?
|
Central Nervous System | 1 | 2013 | 1357 | 0.020 |
Why?
|
Regeneration | 1 | 2014 | 1485 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2503 | 0.020 |
Why?
|
Male | 4 | 2024 | 350118 | 0.010 |
Why?
|
Homeostasis | 1 | 2009 | 3340 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3617 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12072 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14557 | 0.010 |
Why?
|
Aged | 1 | 2024 | 163280 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|